Beard Research, Inc. v. Kates (In re Kates)

485 B.R. 86, 2012 WL 6584994, 2012 Bankr. LEXIS 5805
CourtUnited States Bankruptcy Court, E.D. Pennsylvania
DecidedDecember 18, 2012
DocketBankruptcy No. 11-15325 ELF; Adversary No. 11-0789 ELF
StatusPublished
Cited by28 cases

This text of 485 B.R. 86 (Beard Research, Inc. v. Kates (In re Kates)) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Beard Research, Inc. v. Kates (In re Kates), 485 B.R. 86, 2012 WL 6584994, 2012 Bankr. LEXIS 5805 (Pa. 2012).

Opinion

OPINION

ERIC L. FRANK, Bankruptcy Judge.

TABLE OF CONTENTS

I.INTRODUCTION

II. FACTUAL AND PROCEDURAL BACKGROUND

A. Factual Background

B. The Procedural History of the State Court Litigation and the Bankruptcy Proceedings

C. The Chancery Court Findings Relating to the Sanctions Award
D. The Chancery Court Findings Relating to the Compensatory Damages

1. misappropriation of trade secrets

2. breach of fiduciary duties

3. tortious interference with contractual relations

4. tortious interference with prospective business relations

E. The Debtor’s Unsuccessful Appeal to the Delaware Supreme Court

III. APPLICABLE LEGAL STANDARDS

A. Summary Judgment

B. Dischargeability

1. general principles

2. dischargeability under 11 U.S.C. § 523(a)(6)

C. Issue Preclusion

1. the elements of the doctrine

2. the deductive and inductive methodologies

IV. DISCUSSION

A. The Sanctions Award Is Nondischargeable

1. the Chancery Court findings in granting the adverse inference sanction

2. the Chancery Court findings in denying the default judgment sanction

B. The Compensatory Damages Are Nondischargeable

1. comparison of the legal standards in DUTSA and the Bankruptcy Code

2. the “historical” facts establish the nondischargeability of the Compensatory Damages

C. Allocation of Damages for Purposes of Nondischargeability

V.CONCLUSION

I. INTRODUCTION

Plaintiffs Beard Research, Inc. and CB Research & Development, Inc. hold a pre-petition judgment against Debtor Michael Kates (“the Debtor” or “Kates”) in the amount of $6,784,872.53. The judgment, entered in the Delaware Court of Chancery (“the Chancery Court”), after a trial on the merits of various business tort claims asserted by the Plaintiffs, is comprised of:

[92]*92(a) a sanctions award of $76,906.80 for the Debtor’s spoliation of evidence during the pre-trial phase of the case (“the Sanctions Award”); and
(b) compensatory damages of $4,338,463.00, plus additional sums for pre-judgment and post-judgment interest (“the Compensatory Damages”).

In this adversary proceeding, the Plaintiffs seek a determination that the Sanctions Award is nondischargeable under 11 U.S.C. § 523(a)(6) and the Compensatory Damages are nondischargeable under 11 U.S.C. §§ 523(a)(4) and (a)(6).

The Plaintiffs have filed a Motion for Summary Judgment (“the Motion”), relying exclusively on the findings of fact and conclusions of law set forth in two (2) opinions issued by the Chancery Court in support of the judgment it entered. The Chancery Court issued the first opinion, Beard Research, Inc. v. Kates, 981 A.2d 1175 (Del.Ch.2009) (“Kates J”) in connection with the Sanctions Award and the second opinion, Beard Research, Inc. v. Kates, 8 A.3d 573 (Del.Ch.2010) (“Kates II ”), in connection with the award of Compensatory Damages.

The Plaintiffs assert that the factual findings and legal conclusions in the two (2) opinions preclude the Debtor from contesting the nondischargeability of the State Court Judgment. The Debtor concedes that issue preclusion applies,1 but disputes that the Plaintiffs have carried their burden entitling them to prevail at this stage of the proceeding. In fact, the Debtor argues that the Chancery Court’s findings mandate the entry of judgment in his favor. Resolution of the parties’ competing contentions requires a precise analysis of the Chancery Court’s opinions and a careful application of the elements of the doctrine of issue preclusion.

As set forth below, I conclude that the Plaintiffs have established all of the elements for a determination of nondis-chargeability under 11 U.S.C. § 523(a)(6) with respect to both the Sanctions Award and the Compensatory Damages.2 Accordingly, the Motion will be granted and an order will be entered determining that the debt liquidated in the Chancery Court judgment (hereafter, “the Chancery Court Judgment”) is nondischargeable.

CB Research & Development, Inc. (“CB”) is a chemistry-based research organization (“CRO”) formed in 1991 by Charles Beard (“Beard”). A CRO is a chemistry outsourcing service that provides chemical compounds to end users, such as pharmaceutical companies. CB focused its business on “one-off work”3 and offered a catalog of compounds4 that [93]*93were ready-made and available for immediate delivery to customers. Kates II, 8 A.3d at 583.

In 1999, Beard started a separate company, Beard Research, Inc. (“BR”) to provide fulltime equivalent chemists (“FTE”) to CRO’s (such as CB). FTE’s were chemists who were employed and compensated by BR to provide services to its CRO clients. In return, the clients paid BR annual fees.

CB hired the Debtor in 1998. He later became its Executive Vice President and Director of Marketing. Subsequently, the Debtor received a one-third ownership interest in BR and was appointed as one of its officers and directors. Id. at 581-82.

In December 2002, Pfizer, Inc. (“Pfizer”) and CB entered into a nonexclusive contract pursuant to which Pfizer would provide funding for at least sixteen (16) FTE chemists (at $226,000.00 per year) and a minimum amount of one-off work ($950,-000.00 per quarter) for three (3) years (“the Pfizer/CB Contract”). The Pfizer/CB Contract also contained a “key man clause” which permitted Pfizer to terminate the contract in the event that either Beard or Kates left the company or was reassigned, unless CB and Pfizer agreed to a replacement. Pfizer’s representative in the negotiations leading to the Pfizer/CB Contract was Alan Blize (“Blize”). Id. at 582-83.

Blize was employed by Pfizer as a “molecular broker” and managed Pfizer’s relations with CB and BR. In December 2002, Blize left Pfizer. However, before doing so, in July 2002, Blize accepted a job with (and paychecks from) ASDI, Inc. (“ASDI”), a competitor of the Plaintiffs. Id. at 583.

In 2003, the Debtor and Blize engaged in numerous discussions about the possibility of the Debtor heading a custom synthesis lab at ASDI. In December 2003, the Debtor made a presentation for ASDI’s Board of Directors. Id. at 584. As a result of

Free access — add to your briefcase to read the full text and ask questions with AI

Related

David R. Dingess
D. Delaware, 2025
Olsen v. Dingess
D. Delaware, 2025
Rael v. Gonzales
D. New Mexico, 2025
Lombardi v. Picard
E.D. Pennsylvania, 2022
Scroggins v. Jones
E.D. Pennsylvania, 2022
Menges v. Collins
E.D. Pennsylvania, 2021
Miner v. Mines
E.D. New York, 2021
Walnut Meadows, LLC v. Tzabari
E.D. Pennsylvania, 2020
Compton v. Moschell
W.D. Pennsylvania, 2020
Wynn Las Vegas, LLC. v. Anandani (In re Anandani)
578 B.R. 523 (E.D. Pennsylvania, 2017)
Harris v. Kamps (In re Kamps)
575 B.R. 62 (E.D. Pennsylvania, 2017)
Carmelo v. Mickletz (In re Mickletz)
544 B.R. 804 (E.D. Pennsylvania, 2016)
J & V Developers, Inc. v. Malloy (In re Malloy)
535 B.R. 81 (E.D. Pennsylvania, 2015)
Loucas v. Cunningham (In re Cunningham)
526 B.R. 578 (E.D. Pennsylvania, 2015)
Webb v. Webb (In re Webb)
525 B.R. 226 (M.D. Pennsylvania, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
485 B.R. 86, 2012 WL 6584994, 2012 Bankr. LEXIS 5805, Counsel Stack Legal Research, https://law.counselstack.com/opinion/beard-research-inc-v-kates-in-re-kates-paeb-2012.